Skip to main content
. 2004 Mar 1;141(6):1024–1031. doi: 10.1038/sj.bjp.0705694

Figure 1.

Figure 1

Effect of Ang II (10 nM) (n=9) on UA cyclic GMP content relative to control (n=12), and the effect of pretreatment with either losartan (0.1 μM) (n=8), PD 123319 (1 μM) (n=8) or the combination of both (n=8). **P<0.01 versus control; †P<0.05 versus PD 123319 plus Ang II (one-way ANOVA).